Cytomegalovirus hyperimmunoglobulin and substitution with blood products from antibody-negative donors. A pilot study in bone marrow transplant recipients

Haematol Blood Transfus. 1987:30:538-40. doi: 10.1007/978-3-642-71213-5_95.
No abstract available

MeSH terms

  • Acute Disease
  • Adult
  • Blood Donors
  • Blood Transfusion*
  • Bone Marrow Transplantation*
  • Cyclophosphamide / therapeutic use
  • Cytomegalovirus Infections / prevention & control*
  • Female
  • Graft Enhancement, Immunologic
  • Humans
  • Immunization, Passive*
  • Immunosuppression Therapy
  • Leukemia / complications
  • Leukemia / therapy*
  • Male
  • Pilot Projects
  • Whole-Body Irradiation

Substances

  • Cyclophosphamide